Видео ютуба по тегу Rpg Life Sciences

Margin Will Improve Hereon & Reach The 23-24% Range: RPG Lifesciences | CNBC TV18
Margin Will Improve Hereon & Reach The 23-24% Range: RPG Lifesciences | CNBC TV18
RPG Life Sciences' Yugal Sikri Discusses Week Q4 Performance | Halftime Report | CNBC-TV18
RPG Life Sciences' Yugal Sikri Discusses Week Q4 Performance | Halftime Report | CNBC-TV18
RPG Life Sciences goes 100% digital with Windows 10 devices
RPG Life Sciences goes 100% digital with Windows 10 devices
RPG Lifesciences Q-1 Result analysis | Antim Bazi
RPG Lifesciences Q-1 Result analysis | Antim Bazi
RPG Life Sciences Q2 | Рост внутреннего рынка: 16% против 7,9% в отрасли | Ашок Наир | Бизнес
RPG Life Sciences Q2 | Рост внутреннего рынка: 16% против 7,9% в отрасли | Ашок Наир | Бизнес
RPG Life Sciences Q2 FY26 Earnings Conference Call | Concall.in
RPG Life Sciences Q2 FY26 Earnings Conference Call | Concall.in
Ashok Nair, MD, RPG Life Sciences speaks to CNBC TV18 on the company's Q1 FY25 performance
Ashok Nair, MD, RPG Life Sciences speaks to CNBC TV18 on the company's Q1 FY25 performance
VK Singh, CEO, RPG Life Sciences
VK Singh, CEO, RPG Life Sciences
A Million Thanks | COVID19 | Healthcare Heroes | RPG Life Sciences ...
A Million Thanks | COVID19 | Healthcare Heroes | RPG Life Sciences ...
Yugal Sikri Discusses RPG Life Sciences' Business Outlook | Midcap Radar | CNBC-TV18
Yugal Sikri Discusses RPG Life Sciences' Business Outlook | Midcap Radar | CNBC-TV18
Open To Both API And Formulations Companies When It Comes To M&A: RPG Life Sciences | CNBC TV18
Open To Both API And Formulations Companies When It Comes To M&A: RPG Life Sciences | CNBC TV18
RPG Life Sciences Ltd Q2 FY2025-26 Concall
RPG Life Sciences Ltd Q2 FY2025-26 Concall
RPG Life Sciences Investor Day
RPG Life Sciences Investor Day
RPG Life Sciences, 2-й квартал 2026 финансового года: выручка выросла на 8% по сравнению с предыд...
RPG Life Sciences, 2-й квартал 2026 финансового года: выручка выросла на 8% по сравнению с предыд...
RPG Life Sciences Earnings Call for Q2FY23
RPG Life Sciences Earnings Call for Q2FY23
Q1 Review: Decoding RPG Life Sciences' Results | BQ Prime
Q1 Review: Decoding RPG Life Sciences' Results | BQ Prime
Yugal Sikri, MD, RPG Life Sciences Ltd., One of India's Best Companies to Work For 2020.
Yugal Sikri, MD, RPG Life Sciences Ltd., One of India's Best Companies to Work For 2020.
RPG Life Sciences | Fundamental Analysis | Stock / Share Analysis
RPG Life Sciences | Fundamental Analysis | Stock / Share Analysis
Ashok Nair, MD, RPG Life Sciences speaks to NDTV Profit on the company's Q1 FY25 performance
Ashok Nair, MD, RPG Life Sciences speaks to NDTV Profit on the company's Q1 FY25 performance
RPG Life Sciences Limited Q2FY26 Concall
RPG Life Sciences Limited Q2FY26 Concall
RPG Life Sciences Ltd., One of India's Best Companies to Work For 2020.
RPG Life Sciences Ltd., One of India's Best Companies to Work For 2020.
RPGL Stock | RPG Life Sciences Limited Q2 FY23 Earnings Concall
RPGL Stock | RPG Life Sciences Limited Q2 FY23 Earnings Concall
RPG Life Science Q3: Steady Uptick In Profits, Margins, What's The Future Outlook Of Co? Yugal Sikri
RPG Life Science Q3: Steady Uptick In Profits, Margins, What's The Future Outlook Of Co? Yugal Sikri
CT Renganathan of RPG Life Sciences at Pharma Leaders. Regulations, Reforms are key to Growth.
CT Renganathan of RPG Life Sciences at Pharma Leaders. Regulations, Reforms are key to Growth.